DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» PIM1
PIM1
Identification of PIM1 Substrates Reveals a Role for NDRG1
The Legionella Kinase Legk7 Exploits the Hippo Pathway Scaffold Protein MOB1A for Allostery and Substrate Phosphorylation
Pim1 Inhibition As a Novel Therapeutic Strategy for Alzheimer's Disease
Comprehensive Identification of Proteins in Hodgkin Lymphoma
Rnai Screen Identifies a Synthetic Lethal Interaction Between PIM1 Overexpression and PLK1 Inhibition
1 Identification of PIM1 Substrates Reveals a Role for NDRG1
Repression of the Protein Kinase PIM3 by an Mtorc1-Regulated Microrna
PIM1-Dependent Phosphorylation of Histone H3 at Serine 10 Is Required for MYC-Dependent Transcriptional Activation and Oncogenic Transformation
Characterization of a Protein Kinase B Inhibitor in Vitro and in Insulin-Treated Liver Cells Lisa Logie,1 Antonio J
Exploration of CTCF Post-Translation Modifications Uncovers Serine-224 Phosphorylation by PLK1 at Pericentric Regions During
PIM1 Promotes Survival of Cardiomyocytes by Upregulating C-Kit Protein Expression
Inhibition of ERK 1/2 Kinases Prevents Tendon Matrix Breakdown Ulrich Blache1,2,3, Stefania L
PRODUCTS and SERVICES Target List
A Promising Therapeutic Opportunity in Prostate Cancer
PIM Kinases As Therapeutic Targets Against Advanced Melanoma
WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype
PIM1 PIM1 Kinase Assay
Comprehensive Pan-Cancer Next Generation Sequencing Solid Tumor Panel, Aberration List Updated 08-07-2020 --Page 1
Top View
The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
Lestaurtinib
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase with Potent Antimelanoma Activity
Discovery of Potent and Selective MRCK Inhibitors with Therapeutic
The Kinetics of G2 and M Transitions Regulated by B Cyclins
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
PAI1 Is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208
Phosphorylation of DEPDC5, a Component of the GATOR1 Complex, Releases Inhibition of Mtorc1 and Promotes Tumor Growth
Pim1 Kinase Is Required to Maintain Tumorigenicity in MYC-Expressing Prostate Cancer Cells
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity Johannes C
Identification of Gefitinib Off-Targets Using a Structure-Based Systems
Cancer Susceptibility Mutations in Patients with Urothelial Malignancies the Following Represents Disclosure Information Provided by Authors of This Manuscript
Structural Analysis of PIM1 Kinase Complexes with ATP-Competitive Inhibitors Received: 7 July 2017 Jozefna Bogusz1,2, Karol Zrubek1,2, Krzysztof P
Supporting Information for “A High-Throughput Targeted Proteomic Approach for Comprehensive
Precision Medicine for Diffuse Large B-Cell Lymphoma Megan S
Pim Kinases Promote Cell Cycle Progression by Phosphorylating
Targeting CDK9 for Anti-Cancer Therapeutics